2 suspended. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 2 |
| Phase 1 | 1 | Suspended 1 |
Follow Adenoma: new trials by email Literature Review of Adenoma trials Research Report on Adenoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers XmAb20717 - Microsatellite High Cancers, Peritoneal Mesothelioma | Phase 2 | Suspended | M.D. Anderson Cancer Center | 140 | 2022-08-05 | 2026-10-13 |
| Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment Oshadi D and Oshadi R - Mesothelioma | Phase 1 / Phase 2 | Suspended | Oshadi Drug Administration | 17 | 2016-12-01 | 2018-04-18 |
Mesothelioma, Malignant (2) · Carcinoma, Neuroendocrine (1) · Hodgkin Disease (1) · Mesothelioma (1) · Neoplasms (1) · Small Cell Lung Carcinoma (1) · Uterine Cervical Neoplasms (1)
Lung Diseases (2) · Lung Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Mesothelial (2) · Pleural Neoplasms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Adenocarcinoma (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1)
M.D. Anderson Cancer Center (1) · Oshadi Drug Administration (1)
Israel (1) · United States (1)
Arvind Nageshwara Dasaru, MD (1) · Hovav Nehushtan, Prof. (1)